Эффективность цитопротекторной терапии при инсульте

Abstract

Acute cerebral blood flow disturbances now are the most important medical and social problem. They become a major cause of permanent loss of disability. Given the rising incidence of stroke in working age, it certainly is important. Use of cytoprotector in the treatment of patients with ischemic stroke leads to a statistically significant decrease of neurological deficit, improvement of social and domestic adaptation levels and quality of life. The authors present the results of their own clinical research on the effectiveness of the drug Mexicor® in patients with acute ischemic stroke.

Keywords

• cytoprotection
• stroke
• neurological deficit